Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugate therapies. Our pipeline includes varegacestat, a late-clinical stage GSI; IM-1021, a clinical-stage ROR1 ADC; and IM-3050, a FAP-targeted radiotherapy that recently received IND clearance. We are also advancing a broad portfolio of early stage ADCs pursuing undisclosed solid tumor targets. We are seeking a highly experienced CMC leader to oversee the Chemistry, Manufacturing, and Controls (CMC) strategy and execution for varegacestat. This individual will lead the CMC team through NDA and MAA submissions, enable on-time product launch and sustained commercial supply, support ongoing clinical development, and drive second-generation drug product initiatives. The ideal candidate will demonstrate strong strategic and operational leadership, ensuring all CMC and product lifecycle deliverables are achieved on time, with 'first time right' execution, and in alignment with global commercial and technical objectives. This is a leadership role reporting to the Head of Chemical Process and Analytical Development.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree
Number of Employees
101-250 employees